BMO Capital Markets Increases Cross Country Healthcare Price Target to $12.00 (CCRN)
Equities researchers at BMO Capital Markets boosted their price target on shares of Cross Country Healthcare (NASDAQ:CCRN) from $9.00 to $12.00 in a research report issued on Monday, American Banking News.com reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 14.72% from the stock’s previous close.
Separately, analysts at Cantor Fitzgerald raised their price target on shares of Cross Country Healthcare from $6.00 to $7.00 in a research note to investors on Tuesday, November 12th.
Cross Country Healthcare (NASDAQ:CCRN) traded down 1.13% on Monday, hitting $10.46. 567,728 shares of the company’s stock traded hands. Cross Country Healthcare has a 52 week low of $4.59 and a 52 week high of $10.83. The stock has a 50-day moving average of $8.21 and a 200-day moving average of $6.36. The company’s market cap is $325.1 million.
Cross Country Healthcare (NASDAQ:CCRN) last released its earnings data on Thursday, November 7th. The company reported $0.05 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.01) by $0.06. The company had revenue of $108.00 million for the quarter, compared to the consensus estimate of $111.93 million. During the same quarter last year, the company posted ($0.02) earnings per share. Cross Country Healthcare’s revenue was down 3.8% compared to the same quarter last year. Analysts expect that Cross Country Healthcare will post $0.03 EPS for the current fiscal year.
Cross Country Healthcare, Inc (NASDAQ:CCRN) is engaged in the healthcare staffing services offering a suite staffing and outsourcing services to the healthcare market.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.